Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trial.
Shirahata A, Fukutake K, Mimaya J, Takamatsu J, Shima M, Hanabusa H, Takedani H, Takashima Y, Matsushita T, Tawa A, Higasa S, Takata N, Sakai M, Kawakami K, Ohashi Y, Saito H. Shirahata A, et al. Among authors: mimaya j. Haemophilia. 2012 Jan;18(1):94-101. doi: 10.1111/j.1365-2516.2011.02548.x. Epub 2011 Apr 28. Haemophilia. 2012. PMID: 21535327 Clinical Trial.
An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
Shirahata A, Fukutake K, Higasa S, Mimaya J, Oka T, Shima M, Takamatsu J, Taki M, Taneichi M, Yoshioka A; STUDY GROUP ON FACTORS INVOLVED IN FORMATION OF INHIBITORS TO FACTOR VIII AND IX PREPARATIONS. Shirahata A, et al. Among authors: mimaya j. Haemophilia. 2011 Sep;17(5):771-6. doi: 10.1111/j.1365-2516.2011.02599.x. Epub 2011 Jun 20. Haemophilia. 2011. PMID: 21682824
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd report.
Shirahata A, Fukutake K, Mimaya J, Takamatsu J, Shima M, Hanabusa H, Takedani H, Takashima Y, Matsushita T, Tawa A, Higasa S, Takata N, Sakai M, Kawakami K, Ohashi Y, Saito H. Shirahata A, et al. Among authors: mimaya j. Haemophilia. 2013 Mar;19(2):330-7. doi: 10.1111/hae.12024. Epub 2012 Sep 19. Haemophilia. 2013. PMID: 22989180 Clinical Trial.
Status of anti-HIV-1 chemotherapy in Japan.
Oishi T, Sugiura W, Matsuda M, Abumi H, Okano A, Yamada K, Koike M, Taki M, Ishikawa M, Miura T, Fukutake K, Gouchi K, Ajisawa A, Iwamoto A, Hanabusa H, Mimaya J, Takamatsu J, Takata N, Kakishita E, Higasa S, Yoshioka A, Kashiwagi S, Shirahata A, Nagai Y. Oishi T, et al. Among authors: mimaya j. Jpn J Infect Dis. 1999 Apr;52(2):51-2. Jpn J Infect Dis. 1999. PMID: 10817968 No abstract available.
Prevalence of drug resistance-related mutations among HIV-1s in Japan.
Sugiura W, Matsuda M, Abumi H, Yamada K, Taki M, Ishikawa M, Miura T, Fukutake K, Gouchi K, Ajisawa A, Iwamoto A, Hanabusa H, Mimaya J, Takamatsu J, Takada N, Kakishita E, Yoshioka A, Kashiwagi S, Shirahata A, Nagai Y. Sugiura W, et al. Among authors: mimaya j. Jpn J Infect Dis. 1999 Feb;52(1):21-2. Jpn J Infect Dis. 1999. PMID: 10808258 No abstract available.
Two possible pathways for acquisition of mutations related to nelfinavir resistance.
Sugiura W, Oishi T, Okano A, Matsuda M, Abumi H, Yamada K, Koike M, Taki M, Ishikawa M, Miura T, Fukutake K, Gouchi K, Ajisawa A, Iwamoto A, Hanabusa H, Mimaya J, Takamatsu J, Takata N, Kakishita E, Higasa S, Kashiwagi S, Shirahata A, Nagai Y. Sugiura W, et al. Among authors: mimaya j. Jpn J Infect Dis. 1999 Aug;52(4):175-6. Jpn J Infect Dis. 1999. PMID: 10592904 No abstract available.
116 results